Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

08. Februar 2024 09:10 ET | Quelle: SK Biopharmaceuticals Co., Ltd.

SK Life Science Labs Experts Unveil Latest Scientific Findings at Keystone Symposia on Epigenetic Mechanisms and Cancer Treatment, and the 2nd Annual Molecular Glue Drug Development Summit

KING OF PRUSSIA, Pa., Feb. 08, 2024 (GLOBE NEWSWIRE) -- SK Life Science Labs (formerly Proteovant Therapeutics) a subsidiary of SK Biopharmaceuticals, Co., Ltd., showcased its cutting-edge targeted...
31. Oktober 2023 09:00 ET | Quelle: SK Biopharmaceuticals Co., Ltd.

SK Life Science Labs, a Subsidiary of SK Biopharmaceuticals, Presents Discovery of Oral SMARCA2 Degraders Data at 6th Annual Targeted Protein Degradation Summit

KOREA and KING OF PRUSSIA, Pa., Oct. 31, 2023 (GLOBE NEWSWIRE) -- SK Life Science Labs (formerly Proteovant Therapeutics) a subsidiary of SK Biopharmaceuticals, today will present preclinical data...
12. Oktober 2023 13:00 ET | Quelle: SK Biopharmaceuticals Co., Ltd.

SK Biopharmaceuticals’ Proteovant Therapeutics Presents Preclinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

KOREA and KING OF PRUSSIA, Pa., Oct. 12, 2023 (GLOBE NEWSWIRE) -- SK Biopharmaceuticals, a global biotech focused on the research, development and commercialization of treatments for disorders of...
26. September 2023 10:01 ET | Quelle: SK Biopharmaceuticals Co., Ltd.

SK Biopharmaceuticals’ Proteovant Therapeutics Presents Preclinical Data on IKZF2 Protein Degrader Program and MOPED™ Molecular Glue Screening Platform at the 20th Annual Discovery on Target Conference

KOREA and KING OF PRUSSIA, Pa., Sept. 26, 2023 (GLOBE NEWSWIRE) -- SK Biopharmaceuticals, a global biotech focused on the research, development and commercialization of treatments for disorders of...